HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): William H. Frist Philip E. Oyer John C. Baldwin Edward B. Stinson Norman E. Shumway Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Frist, W. H. Articles by Shumway, N. E. Search for Related Content PubMed PubMed Citation Articles by Frist, W. H. Articles by Shumway, N. E.

Ann Thorac Surg 1987;44:242-246
© 1987 The Society of Thoracic Surgeons

---

Articles

HLA Compatibility and Cardiac Transplant Recipient Survival

Department of Cardiovascular Surgery, Stanford University Medical Center, Stanford, CA

^* Address reprint requests to Dr. Frist, Vanderbilt University Medical Center, 1211 21st Ave S, Suite 338, Nashville, TN 37212.

Although the major histocompatibility complex has been linked with the control and expression of immune response in mammalian species, its importance for heart transplantation has not been demonstrated. The relationship of patient survival to human lymphocyte antigen (HLA) (A and B loci) compatibility was studied in 164 consecutive cyclosporine-treated patients who underwent orthotopic heart transplantation between 1980 and 1986 at Stanford University Medical Center. All patients receiving a transplant within this time frame were included except those for whom HLA typing was unavailable. A mismatched antigen was defined as an antigen present in the donor but not in the recipient. The actuarial four-year survival (Cutler-Ederer) for the 19 patients with 0 or 1 mismatch was 88 ± 8%; for the 39 patients with 2 mismatches, 70 ± 12%; for the 73 patients with 3 mismatches, 59 ± 7%; and for the 33 patients with 4 mismatches, 54 ± 14%. Both actuarial and linear rate analyses revealed no significant correlation between HLA mismatching and rejection rate, likelihood of death from rejection, or length of time to first episode of rejection.

Patients with 3 or 4 mismatches had significantly (p < 0.05) more infections than those with fewer mismatches. By actuarial analysis, a trend toward a higher number of deaths from rejection and infection was observed in the groups with 3 and 4 mismatches, but it did not achieve statistical significance. The data demonstrate that well-matched HLA grafts are associated with better long-term survival and fewer infections in cardiac transplant patients.

This article has been cited by other articles:

				K. V. Arom and F. L. Grover Adult cardiac surgery during the first 50 years of the Southern Thoracic Surgical Association Ann. Thorac. Surg., November 1, 2003; 76(90050): S17 - 46. [Abstract] [Full Text] [PDF]

				V. J. DiSesa, R. Mull, E. S. Daly, L. H. Edmunds Jr, D. M. Mancini, and H. J. Eisen Cardiac transplant donor heart allocation based on prospective tissue matching Ann. Thorac. Surg., October 1, 1994; 58(4): 1050 - 1053. [Abstract] [PDF]

				G. E. Sarris, K. A. Moore, J. S. Schroeder, S. A. Hunt, M. B. Fowler, H. B. Valantine, R. H. Vagelos, M. E. Billingham, P. E. Oyer, E. B. Stinson, et al. Cardiac transplantation: The Stanford experience in the cyclosporine era J. Thorac. Cardiovasc. Surg., August 1, 1994; 108(2): 240 - 252. [Abstract] [Full Text]

				P. Terasaki Getting the most mileage from donated hearts Ann. Thorac. Surg., February 1, 1990; 49(2): 177 - 178. [PDF]

				V. J. DiSesa, P. C. Kuo, K. A. Horvath, G. H. Mudge, J. J. Collins Jr, and L. H. Cohn HLA histocompatibility affects cardiac transplant rejection and may provide one basis for organ allocation Ann. Thorac. Surg., February 1, 1990; 49(2): 220 - 224. [Abstract] [PDF]

				M. S. Sweeney, M. P. Macris, O. H. Frazier, J. T. Sinnott, M. Peric, and H. A. McAllister Jr The Treatment of Advanced Cardiac Allograft Rejection Ann. Thorac. Surg., October 1, 1988; 46(4): 378 - 381. [Abstract] [PDF]